quinapril/hydrochlorothiazid aurobindo 20/25 mg filmtabletten
puren pharma gmbh & co. kg (8034441) - quinaprilhydrochlorid; hydrochlorothiazid - filmtablette - quinaprilhydrochlorid (23354) 21,66 milligramm; hydrochlorothiazid (00512) 25 milligramm
quinapril/hydrochlorothiazid aurobindo 20/12,5 mg filmtabletten
puren pharma gmbh & co. kg (8034441) - quinaprilhydrochlorid; hydrochlorothiazid - filmtablette - quinaprilhydrochlorid (23354) 21,66 milligramm; hydrochlorothiazid (00512) 12,5 milligramm
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).
primox plus 15 mg/25 mg
ucb pharma gmbh (3002761) - hydrochlorothiazid; moexiprilhydrochlorid - filmtablette - hydrochlorothiazid (00512) 25 milligramm; moexiprilhydrochlorid (26115) 15 milligramm
hydromorphon-hcl glenmark 2 mg hartkapseln, retardiert
glenmark arzneimittel gmbh (8139306) - hydromorphonhydrochlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; hydromorphonhydrochlorid (00108) 2 milligramm
hydromorphon-hcl glenmark 24 mg hartkapseln, retardiert
glenmark arzneimittel gmbh (8139306) - hydromorphonhydrochlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; hydromorphonhydrochlorid (00108) 24 milligramm
hydromorphon-hcl glenmark 16 mg hartkapseln, retardiert
glenmark arzneimittel gmbh (8139306) - hydromorphonhydrochlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; hydromorphonhydrochlorid (00108) 16 milligramm
hydromorphon-hcl glenmark 8 mg hartkapseln, retardiert
glenmark arzneimittel gmbh (8139306) - hydromorphonhydrochlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; hydromorphonhydrochlorid (00108) 8 milligramm
hydromorphon-hcl glenmark 4 mg hartkapseln, retardiert
glenmark arzneimittel gmbh (8139306) - hydromorphonhydrochlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; hydromorphonhydrochlorid (00108) 4 milligramm